Abstract
Background This study assessed the current state of knowledge, including social determinants of health considerations, regarding mpox acquisition and severity in Southwest and Littoral regions, Cameroon.
Methods This was a descriptive cross-sectional study carried out with mpox cases from Southwest and Littoral regions. Perceived knowledge and determinants of mpox were assessed via a self-reported questionnaire. Descriptive and inferential statistical analyses were performed.
Results A total of 394 participants took part in the study. With respect to the socio-demographic characteristic of the study population, 356 (89.4%) were Cameroonians, 267 (67.1%) were females, and 261 (65.60%) were students. With regards to mpox knowledge, 278 (69.8%) of the respondents declared that mpox is caused by a virus, with 12 (3.0%) individuals responding that the signs and symptoms associated with mpox were back and/or muscle pain, skin rash, fever, pustules, and exhaustion. Knowledge scores were found to be dependent on socio-demographic background. Based on socio-behavioral determinants of mpox, 348 (87.4%) of the participants reported consumption of wild game (bushmeat) and 92 (23.1%) participants reported that mpox can be treated traditionally in their culture. Regarding epidemiological determinants, 42 (10.6%) participants reported that mpox can be transmitted through direct contact with lesions, 120 (30.2%) reported prior smallpox infection, and 47(11.8%) reported prior mpox infection. Based on risk factors reported, 180 (46.7%) of the participants had close contact with confirmed or probable cases of mpox and 196 (49.2%) were present in healthcare facilities where mpox cases were managed.
Conclusion Multiple knowledge gaps regarding mpox and MPXV were documented in the population in Southwest and Littoral regions of Cameroon. Reported social and behavioral determinants included the state of instability of the southwest region and population displacement in the bushes/forests, wild game consumption without proper cooking and poor hygiene were associated with mpox infection risk perception and vulnerability. On the epidemiological aspects increased instability, travel out of town, and limited remote rural chickenpox vaccination coverage were reported to increase risk, vulnerability, and spread of mpox within these endemic communities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We are grateful to all hospitals and health center authorities and participants for their cooperation. This work was supported by the International Mpox Research Consortium (IMReC) through funding from the Canadian Institutes of Health Research and the International Development Research Centre (Grant No. MRR-184813) as well as a Tier 2 Canada Research Chair in the Molecular Pathogenesis of Emerging and Re-Emerging Viruses (JK) and a Tier 2 Canada Research Chair in Program Science and Global Public Health (SYS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
An ethical clearance was provided from the Institutional Ethical Review Board (IERB), Faculty of Health Sciences, at the University of Douala, Cameroon (including local authorizations from Regional Delegate and Administrator at district health areas and district hospitals in Southwest and Littoral regions).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
